APA

Watson A. M., Mylin L. M., Thompson M. M. & Schell T. D. (20130221). Modification of a tumor antigen determinant to improve peptide/MHC stability is associated with increased immunogenicity and cross-priming a larger fraction of CD8+ T cells. : Journal of immunology (Baltimore, Md. : 1950).

Chicago

Watson Alan M, Mylin Lawrence M, Thompson Megan M and Schell Todd D. 20130221. Modification of a tumor antigen determinant to improve peptide/MHC stability is associated with increased immunogenicity and cross-priming a larger fraction of CD8+ T cells. : Journal of immunology (Baltimore, Md. : 1950).

Harvard

Watson A. M., Mylin L. M., Thompson M. M. and Schell T. D. (20130221). Modification of a tumor antigen determinant to improve peptide/MHC stability is associated with increased immunogenicity and cross-priming a larger fraction of CD8+ T cells. : Journal of immunology (Baltimore, Md. : 1950).

MLA

Watson Alan M, Mylin Lawrence M, Thompson Megan M and Schell Todd D. Modification of a tumor antigen determinant to improve peptide/MHC stability is associated with increased immunogenicity and cross-priming a larger fraction of CD8+ T cells. : Journal of immunology (Baltimore, Md. : 1950). 20130221.